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ABSTRACT 
The effect of parenteral administration of vitamin E during the pregnancy and 
lactation period of ewes and their lambs on innate and humoral components of the 
immune system was investigated in a 3 part study. 1.) Pregnant/Lactating ewes: 
Fifteen pregnant Dorset sheep were supplemented with vitamin E (30 IU d-a-
tocopherol /Kg body weight (BW), E, n=lO) or placebo (emulsified base, P, n=5) from 
the last trimester of gestation through weaning. Blood and colostrum were analyzed 
every 2 wk for a-tocopherol, selenium, glutathione peroxidase activity, lysozyme 
activity, total lgG and IgG antibodies against tetanus toxoid. 2.) Lambs (0-8wks): 
Lambs born to E and P supplemented ewes received either vitamin E (30 IU d-a-
tocopherol /Kg BW) or placebo (emulsified base) every 2 weeks from birth through 8 
wk of age. This resulted in four treatment groups: E/E (n=lO), E/P (n=l 1), PIE (n=4), 
PIP (n=5). The lambs were sampled every other week and their blood was analyzed as 
for the ewes. 3.) Lambs (Vaccination period): When the youngest lamb reached 8 
wks of age all lambs were vaccinated as a group against Clostridium perfringens and 
Clostridium tetani. Booster va~cinations were given 4 wk later. Blood was sampled 
prior to primary vaccination, 1 wk post vaccination and then every 2 wk until 7 wk 
post vaccination. Results: Pregnant/Lactating ewes: Serum vitamin E concentrations 
increased over time in supplemented ewes as compared to placebo ewes. Colostrum 
vitamin E levels were also increased in supplemented versus placebo ewes. Vitamin E 
supplementation did not influence plasma selenium, glutathione peroxidase activity 
and serum lysozyme, IgG and IgG against tetanus toxoid in the serum or colostrum of 
ewes. There were fluctuations within treatment in the production of IgG in response 
to parturition. Lambs (0-8wks): Lambs directly supplemented with vitamin E in 
addition to maternal supplementation (E/E) had higher levels of serum a-tocopherol 
than the placebo group (PIP). There were no differences in plasma selenium, 
glutathione peroxidase activity, serum lysozyme, IgG and IgG against tetanus toxoid 
concentrations between groups. There was a loss of maternal antibodies over time in 
all lambs. Serum lysozyme activity was higher at birth, prior to ingestion of 
colostrum, in lambs that received maternal vitamin E supplementation compared to the 
lambs that received only direct vitamin E supplementation. Lambs (Vaccination 
period): Serum a-tocopherol levels increased in lambs that received direct vitamin E 
supplementation (E/E and PIE) irrespective of maternal supplementation (PIP and 
EIP). Plasma selenium, glutathione peroxidase activity, serum lysozyme and IgG did 
not differ between treatment groups. There was an increase in the production of IgG 
against tetanus toxoid in response to booster vaccination in PE lambs. Conclusions: 
Supplemental vitamin E to the ewes and lambs, at 30 IU/Kg BW, had a modest effect 
on parameters used in this study to assess innate and humoral immunity. 
(Key words: vitamin E, ewe, IgG, tetanus toxoid) 
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PREFACE 
This thesis is written in a manuscript format. Chapter 1 includes detailed information 
on current vitamin E research. A condensed paper about the study is presented in 
chapter 2. Additional details on methods used throughout the study are presented in 
the appendices. 
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CHAPTER I: 
Review of Literature 
INTRODUCTION 
The immune system protects the host from invading microorganisms through 
complex pathways of recognition and elimination. Disease occurs when the immune 
system is compromised by infectious pathogens. Humans and animals are susceptible 
to infections throughout their lives, but are more susceptible when undergoing 
physiological stress, malnourishment or at varying stages of life such as birth, 
gestation and lactation. Infections are the major cause of production losses and can 
affect animals of all ages. The nutritional status of an animal can influence host 
resistance and susceptibility to disease (Hidiroglou, et al., 1992). Effects of nutrition 
on disease resistance have long been recognized and the knowledge is being applied to 
farm animal production systems and particularly to ruminants. Nutritional 
supplementation to improve host immunity has always been an area of interest to 
researchers and is the subject of this thesis. 
There are 5.7 million sheep and lambs in United States (USDA, 2008). These 
sheep are used for their meat, wool, milk, hide, and other by products. Losses to the 
sheep industry from nonpredator causes account for $33 million annually (USDA, 
2005) with the majority of these losses attributed to infections. About 15-50% 
mortality is seen before weaning, with the most of the mortality occurring in first 24 
hrs of life (Bekele, et al., 1992, Rowland, et al., 1992). This increased susceptibility 
can be attributed to immature immune system of the neonates. 
Supplementation with vitamin E has been shown to modulate immune function 
in humans (Meydani, et al., 1990) and several species of animals including ruminants 
(Afzal, et al. , 1984, Beharka, et al., 1997, Ellis and Vorhies, 1976, Moriguchi and 
Muraga, 2000, Reddy, et al., 1987, Ritacco, et al., 1986, Segagni, 1955, Tengerdy, 
1989). Although vitamin E has been investigated extensively, little research has been 
undertaken to establish whether supplementation of vitamin E to small ruminants 
during gestation, lactation and early in life has a beneficial impact on immune function 
in these animals. 
Innate Immunity 
In general, the immune system can be broadly categorized into two divisions: 
innate and adaptive. The cells of the innate immune system serve as the first line of 
defense and act nonspecifically towards antigens. The innate response is mediated 
through antimicrobial molecules such as lysozyme, lactoferrin, nitric oxide, and the 
various cells of defense i.e. natural killer cells, macrophages, neutrophils, and mast 
cells. 
Lysozyme is a hydrolytic enzyme present in serum, tears, seminal fluid, milk, 
and in phagocytic cells. It has bactericidal effect on most gram-positive and some 
gram-negative bacteria and viruses. It binds to the surface of the susceptible 
pathogens and promotes their lysis (Tizard, 2000). 
Glutathione peroxidase (GSH-Px) is an enzymatic antioxidant that belongs to 
the selenoprotein family and catalyzes the reduction of hydrogen and lipid peroxides 
to their corresponding alcohols (Loscalzo, 2008). It plays a key role in maintaining 
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the physiological balance between prooxidants and antioxidants (Zablocka and Janusz, 
2008). 
Adaptive Immunity 
The adaptive immune response constitutes humoral and cell mediated 
immunities that use B and T lymphocytes respectively to neutralize pathogens in an 
antigen specific manner. Humoral immunity is mediated through antibodies whereas 
cell mediated immunity is mediated through cytokines, namely interleukins and 
interferons, that act as chemical messengers (Tizard, 2000). B-lymphocytes that 
mature in bone marrow provide humoral immunity through antibodies - IgG, IgM, 
IgA, IgD, and IgE. Antibodies bind to specific antigens and enhance their destruction 
and elimination. Blood contains high levels of IgG followed by IgM and then IgA. T 
lymphocytes mature in thymus and are divided into T helper and T cytotoxic cells to 
lyse extracellular and intracellular organisms. Cytokines produced by the cellular 
immune system act as chemical messengers further activating Band T lymphocytes as 
well as other immune cells such as natural killer cells and macrophages (Tizard, 
2000). 
Maternal immune system 
The maternal immune system during the transition period, which includes 
pregnancy, parturition, and lactation, is under extreme stress. The stress during 
pregnancy and increased metabolic demands during parturition and lactation result in 
increased production of reactive oxygen species leading to oxidative stress (Spears and 
Weiss, 2008). In addition to these drains on the animal's physical resources, they 
must be in a suitable physiological state to ensure repair of any tissue damaged during 
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parturition, and to maintain resistance to infections (Andrieu, 2008). This 
physiological stress can have a negative impact on neutrophil function, antibody 
responses, and cytokine production by immune cells (Spears and Weiss, 2008). The 
compromised immune system of the dam not only influences their own immune 
function but can also affect their offspring. 
Neonatal immune system 
Neonates have an immature immune system that renders them susceptible to a 
wide variety of bacterial and viral pathogens. They have impaired immune responses 
due to a range of deficiencies in both adaptive and innate immunity. Additionally, 
maternal antibodies transferred with colostrum activate and regulate innate responses 
present in the neonate to fight against infection, but at the same time can interfere with 
the neonates ability to develop specific immunity against various antigens (Chase, et 
al., 2008). The interaction of the maternal and neonatal immune system is depicted in 
Fig. I. Immunity is low at birth and a peak in passive immunity occurs after ingestion 
of colostrum. Passive immunity offers protection to the newborn through maternal 
antibodies. Active immunity, which has to be developed by the newborn, is low at 
birth and gradually increases with age. When passive immunity starts to wane and 
active immunity is not fully established to confer sufficient protection there is a 
window of susceptibility to infections (Chase, et al., 2008). 
Infections are a major cause of neonatal losses. Newborns can acqmre 
infections either from the environment or from the dam. Additionally, maternal 
honnones produced prior to parturition can lead to immunosuppression in the 
offspring (Jacob, et al., 2001). Overall, these infections, coupled with a naYve immune 
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system, leads to significant losses either from mortality or decreased production 
efficiency. To protect newborns from infectious pathogens and increase their disease 
resistance, the immune function of the dam, newborn or both needs to be enhanced. 
As the epitheliochorial placenta of ruminants does not allow passage of 
immunoglobulins from dam to fetus, colostrum is the only efficient source of immune 
components and nutrients to the neonate. Colostrum contains proteins, 
immunoglobulins, nonprotein nitrogen, fat, vitamins and minerals. Hence, improving 
the dam's immune system may increase immunoglobulin transfer to the newborns 
through the colostrum. Boosting the newborns own immune system will increase their 
resistance to infections. Any measures that can be shown to improve host resistance to 
infections will have a major impact in reducing morbidity, mortality, and improving 
production efficiency. 
REACTIVE OXYGEN SPECIES AND ANTIOXIDANTS 
The maternal immune system during gestation and lactation and neonatal 
immune system is under extreme physiological stress. During these periods, there can 
be increased production of reactive oxygen species which can be harmful to the host. 
In aerobic organisms, oxygen is reduced to water, the end product of 
mitochondrial respiration. During this process, there is leakage of single electrons 
leading to the partial reduction of 02 to superoxide anion (02.-) (Frei, 1994). These 
free radicals (reactive oxygen, nitrogen and chlorine species) due to their unpaired 
electrons are highly unstable and reactive. In addition to the electron transport, there 
are various endogenous pathways for the production of reactive oxygen species 
(ROS): Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase in 
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phagocytic cells (neutrophils and monocytes), xanthine oxidase, epinephrine, and 
quinoid substrates, such as coenzyme QlO and the cytochrome P450 system (Frei, 
1994). 
Beneficial aspects of ROS 
Recent work on reactive oxygen species has revealed their beneficial aspects to 
the host in disease prevention by assisting the immune system in cell signaling and 
playing an essential role in apoptosis (Seifried, et al., 2007). Innate immune response, 
characterized by the production of ROS within the phagocytic cells such as 
neutrophils and macrophages is a crucial event in the phagocytosis and subsequent 
destruction of the invading pathogen (Bogdan, et al., 2000, Droge, 2002). During the 
respiratory burst, high levels of superoxide anions and hydrogen peroxide are 
produced by NADPH oxidase which is also a part of innate defense (Segal, et al., 
2000). Hence, any activities that can block the production of ROS may result in 
increased bacterial or fungal infections and increased mortality (Deforge, et al., 1993, 
Segal, et al., 2000). 
Deleterious aspects of ROS 
The ROS formed during cellular processes may damage various biological 
macromolecules, which includes damage to cellular membranes and lipoproteins by 
lipid peroxidation, damage to proteins leading to structural changes, altered enzyme 
activity and oxidative damage to DNA (Frei, 1994). 
Antioxidants protect biological macromolecules from harmful effects of free 
radicals either by scavenging the free radicals or by stopping free radical propagation 
(Frei, 1994). The antioxidant defense can be classified into enzymatic and 
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nonenzymatic defenses. Enzymatic includes Glutathione peroxidase (GsHPx) , 
catalase and superoxide dismutase (SOD) whereas nonenzymatic includes vitamin E, 
vitamin C, ~-carotene and others (Evans and Halliwell, 2001). 
VITAMINE 
Vitamin E is a lipid soluble vitamin discovered in 1922 by Evans and Bishop 
(Evans and Bishop, 1922). The active substance was isolated by Evans in 1936 and 
was named as tocopherol which means "to bear offspring" as it was shown to prevent 
sterility in rats (Emerson, et al., 1936). Since then, there has been extensive research 
directed towards the mechanism and role of this multifunctional vitamin. 
Structure of vitamin E 
Vitamin E was first found in wheat germ oil and lettuce (Wang and Quinn, 
1999). Vitamin E is also present in many plants, legume and fruit sources in nature 
(NIH, 2009). Vitamin E occurs as eight naturally occurring compounds called 
tocopherols and tocotrienols which differ in their biological activity (IUPAC-IUB, 
1982) and the saturation of phytal side chain (Fig. 2). Different isoforms of vitamin E 
include a-, ~-, y-, 8-tocopherols and a-, ~-, y-, 8-tocotrienols (Kayden and Traber, 
1993). Within each group a-, ~-, y-, 8 are designated depending on the position and 
number of methyl groups on the aromatic ring. Among all the forms of vitamin E, a-
tocopherol has the highest biological activity attributed to a higher number of methyl 
species that can scavenge the peroxyl radicals (Meydani, 1995). 
Metabolism of vitamin E 
As a fat soluble vitamin, the metabolism of vitamin Eis closely related to other 
lipids and lipoproteins. In the small intestine, vitamin E is integrated into micelles 
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which are composed of products of lipid hydrolysis, biliary secretions and dietary 
lipids (Rimbach, et al., 2002). Micelle formation facilitates the absorption of vitamin 
E and the action of pancreatic lipases which further aid in the absorption of vitamin E 
into the enterocytes lining the intestinal lumen (Brigelius-Flohe and Traber, 1999). 
Vitamin E is then packaged in the enterocytes along with other lipids, as chylomicrons 
or chylomicron remnants, which are absorbed and carried by lymphatic circulation to 
the liver (Bjomeboe, et al., 1987, Kayden and Traber, 1993, Traber, et al., 1986). 
In the liver a- tocopherol is secreted into plasma in conjunction with very low 
density lipoprotein (VLDL) (Cohn, et al., 1988). Alpha tocopherol associated with 
VLDL in plasma can have different fates, it can either be transferred to LDL during 
VLDL catabolism, get delivered to HDL during lipolysis or get transferred back to the 
liver via VLDL remnants (Kayden and Traber, 1993). Liver regulates the secretion 
and excretion of different forms of tocopherol. The other forms of ingested 
tocopherol, other than alpha tocopherol undergoe rapid clearance via bile (Kayden and 
Traber, 1993). This preferential secretion of alpha tocopherol by liver is due to a-
tocopherol transfer protein ( a-TTP) as observed in knockout mice experiments 
(Leonard, et al., 2002) and patients who were deficient in a-TTP (Traber, et al., 1990) 
The major route of excretion for vitamin E is through the feces. Urinary excretion of 
vitamin E in the form of carboxyethyl-hydroxychromane (CEHC) metabolites also 
takes place in case of excess vitamin E intake (Brigelius-Flohe and Traber, 1999). 
Mechanism of action of vitamin E 
Vitamin E is widely known for its effective chain breaking antioxidant 
function (Azzi, 2007). Vitamin E is present in all biological cell membranes and 
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offers protection to the cell membrane lipids from peroxidation and maintains their 
structural integrity. Cellular integrity is very important for receiving and responding 
to the messages needed to produce an effective immune response (Latshaw, 1991). 
Although, vitamin E content varies throughout the body, it is present in highest 
concentrations in tissues with high lipid content (Combs, 1991) (e.g., liver and 
adipose tissue). It is also known for scavenging the free radicals produced during 
normal cellular metabolism and during various immune mechanisms like phagocytosis 
and respiratory burst (Hogan, et al., 1993a). 
Vitamin E (a - TOH) works as an antioxidant by donating a hydrogen group to 
the unstable free radicals (ROO-) forming stable lipid hydroperoxide (ROOH) thereby 
protecting the cell membrane by maintaining its integrity and stability (Fig. 3). During 
this process there is production of a- tocopheroxyl radical (a TO-) which is stable as 
compared to the other free radicals. This alpha tocopheroxyl radical is restored back 
to vitamin E in the cell by vitamin C, glutathione, ubiquinone and other pathways 
(Packer, et al., 1997). 
Non antioxidant functions of vitamin E 
Alpha tocopherol inhibits protein kinase C (PKC) activity, a signaling 
molecule that can regulate cell proliferation. This specific inhibitory effect on cell 
proliferation contributes to the anti-atherosclerosis and anti-tumor effects of vitamin E 
(Azzi, et al., 2002). Vitamin E also inhibits platelet aggregation by Protein kinase C 
dependent mechanism and prevents thrombus formation in the blood vessels (Azzi, et 
al., 2002). Vitamin E inhibits prostaglandin E2 production by macrophages, which 
has a suppressive effect on T cells (Meydani, et al., 1997, Meydani, et al., 1986). 
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Supplementation of vitamin E to old mice enhanced the expression of cell cycle 
related proteins that aid in entering into mitotic phase and help in DNA replication 
(Pelizon, 2003, Quadri, et al., 1998). In cancer cells, vitamin E was hypothesized to 
prevent the proliferation of cells by down regulating cell cycle regulatory proteins (Ni, 
et al. , 2003, Turley, et al., 1997) 
Vitamin E deficiency 
A vitamin E concentration < 2ug/ml in serum/plasma is considered deficient 
(NRC, 2007). Vitamin E deficiency, alone or in conjunction with selenium 
deficiency, has been linked to several clinical syndromes that are variably manifested 
in a wide variety of species. The most common and well described clinical 
manifestation due to the deficiency of vitamin E and selenium is white muscle disease 
(WMD), also known as nutritional muscular dystrophy in lambs, calves, and foals 
(Abutarbush and Radostits, 2003). In lambs, the clinical signs due to WMD include 
weakness, stiffness, inability to stand and curved back (Deger, et al., 2008). 
Postmortem examination reveals necrosis, mineralization, and fibrosis of the skeletal 
and cardiac muscle (Beytut, et al., 2002, Bostedt and Schramel, 1990). Vitamin E 
deficiency is thought to be the cause of equine motor neuron disease and equine 
degenerative myeloencephalopathy m equines, exudative diathesis and 
encephalomalacia in poultry, mulberry heart disease and hepatitis dietetica in pigs, and 
hepatic necrosis in rats. 
Previous studies have shown that a deficiency of vitamin E has negative 
impact on both the humoral and cell mediated immunity. A study on vitamin E 
deficient animals showed decreased natural killer cell (NK) activity and decreased 
10 
phagocytosis by polymorphonuclear cells (Moriguchi and Muraga, 2000). Pigs and 
dogs fed a diet deficient in selenium and vitamin E decreased lymphocyte proliferation 
to mitogens (Lessard, et al., 1993). A study in selenium and vitamin E deficient mice 
reported decreased resistance to gastrointestinal nematode infection (Smith, et al., 
2005). 
A deficiency in antioxidant nutrients like vitamin E and selenium can increase 
viral pathogenicity by decreasing immune response of the host which in turn can cause 
mutations in a benign virus transforming it into a virulent strain (Beck, et al., 1994, 
Beck, et al., 2005). This new aspect of nutrition altering viral pathogenicity was a 
breakthrough in nutritional immunology. 
Toxicity of vitamin E 
Evidence of vitamin E toxicity is rare. According to NRC, 2006 up to 70 
IU/Kg body weight (BW)/day is considered safe. However, vitamin E during the 
process of scavenging free radicals forms tocopheroxyl radical which can act as 
prooxidant when given in large quantities and which, if not restored back by vitamin C 
or glutathione, can produce hcumful effects (Bell and Grochoski, 2008). Recently, 
some researchers have reported increased mortality and cardiovascular diseases with 
higher levels of vitamin E supplementation in humans (Clarke, et al., 2008). 
VITAMIN E AND IMMUNITY 
The effect of vitamin E on disease resistance has been studied in a wide variety 
of animal species. Vitamin E has been shown to modulate both the innate and 
adaptive components of the immune system (Han, et al., 2006, Hogan, et al., 1992, 
Singh, et al., 2006, Tanaka, et al., 1979, Tengerdy, et al., 1973). Studies by Meydani 
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and Moruguchi demonstrated that vitamin E is required to maintain immune function 
in the elderly (Meydani, et al., 1990) and improve the decline in cellular immunity that 
occcurs with aging (Meydani, et al., 1986, Sakai and Moriguchi, 1997). 
Vitamin E and innate immunity 
Vitamin E supplementation has been shown to improve neutrophil function in 
cows during calving period (Hogan, et al., 1990, Hogan, et al., 1992). Vitamin E in 
combination with selenium increased neutrophil function in dairy cows (Gyang, et al., 
1984). A study conducted on geriatric horses supplemented with parenteral vitamin E 
showed an increase in the level of bacterial killing in supplemented horses but lack of 
significant effect on serum lysozyme activity (Petersson, Unpublished data). Sows fed 
72 ru of a- tocopherol/kg of feed, during pregnancy and lactation improved their 
piglets serum lysozyme concentrations at 1 week of age, but had a negative impact 
when they were fed with 202 IU/kg of feed (Babinszky, et al., 1991). 
Selenium and vitamin E supplementation in the cow during late stages of 
pregnancy (Lacetera, et al., 1996) and during the periparturient period (Weiss, et al., 
1990) increased GSH-Px activity in cows and their calves. Supplementation with 
3000 IU/day of vitamin E during transition period in cows prevented the decrease in 
superoxide anion production in neutrophils and Interleukin- I production when 
compared to control cows (Politis, et al., 1995). Rats fed 100-2500 mg/Kg diet of 
vitamin E showed increased phagocytic activity in alveolar macrophages, which was 
dose dependent (Moriguchi, et al., 1990). However, vitamin E did not influence the 
measures of mammary macrophage function in dairy cows (Politis, et al., 1995, 
Politis, et al., 1996). Incidence of clinical mastitis (Smith, et al., 1984, Weiss, et al., 
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1997), retained placenta (Erskine, et al., 1997, Miller, et al., 1993) and metritis 
(Erskine, et al., 1997) was reduced in cows supplemented with oral or parenteral 
vitamin E. More recently, a study conducted on murine peritoneal macrophages 
showed that supplementation with vitamin E can safeguard the morphology of 
immune cells like macrophages from the effect of peroxidative agents (Kaur, et al., 
2009). Studies supplementing vitamin E and selenium during dry period in ewes 
(Morgante, et al., 1999), reported an increase in blood glutathione peroxidase activity, 
but no significant effect on plasma lysozyme activity. 
Vitamin E and Humoral immunity 
In 1973, Tengerdy et al. supplemented mice with vitamin E (60-180 mg/Kg of 
feed) and reported a 30-40% enhancement in the humeral immune response against 
sheep red blood cells (SRBC) and tetanus toxoid antigens (Tengerdy, et al., 1973). In 
this study, they demonstrated that the increase in hum oral immunity was the primary 
immune response, which includes early stage of immunocyte development and 
proliferation. Dietary supplementation of vitamin E (300 mg/kg diet) to chickens 
significantly increased survival rate upon challenge with E. coli and the protection was 
attributed to increased antibody production and increased phagocytosis (Tengerdy and 
Brown, 1977). 
Studies during gestation period Supplementation with parenteral selenium (5mg/100 
kg BW) and dl a-tocopherol acetate (25 IU/Kg BW) during the late stages of 
pregnancy, did not influence plasma IgG concentrations of cow or their calves 
(Lacetera, et al., 1996). In agreement with the previous study, pigs supplemented with 
vitamin E at 22- 88 IU/ kg feed during gestation and 55- 220 IU/kg feed during 
13 
lactation had no effect of vitamin E on total IgG, IgM, IgA in plasma, colostrum and 
milk of gilts and their piglets (Nemec, et al., 1994). Gentry et al. reported that lambs 
from ewes injected with 1500 IU vitamin E, 21 d before parturition, had greater 
concentrations of serum IgG than lambs born to control ewes (Gentry, 1992a). 
Conversely, supplementation of pregnant ewes with 400 IU of vitamin E/ewe/day, 32 
days to 0 day prior to lambing, did not have any effect on ewe and lamb serum IgG 
(Daniels, et al., 2000). 
Studies in young animals Calves supplemented with oral vitamin E and C alone or in 
combination did not produce any significant increase in IgG and IgM response 
(Hidiroglou, et al., 1995). The IgG results were in agreement with Reddy et al. in 
calves receiving 1400 -2800 IU of oral dl-a-tocopherol acetate and 1400 IU dl-a-
tocopherol parenterally but IgM was significantly higher in the orally supplemented 
calves (Reddy, et al., 1986). In a recent study, neonatal calves supplemented with 
2000 IU of parenteral vitamin E weekly, starting at birth until the age of two weeks, 
showed an increase in the total IgG concentration and IgM concentration on day 22 
(Pekmezci and Cakiroglu, 2009). 
Vitamin E supplementation and vaccination response 
Vaccination is an important tool in controlling and eradicating a disease. 
Immunological responses to specific pathogens can be increased by vaccination. 
Hence, the greater the production of antibodies against an antigen, the greater the 
protection offered against the disease. 
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Research in pigs, chickens, and other animals 
Dietary vitamin E supplementation at 100 IU/ Kg of feed to 6-8 wk old pigs 
yielded enhanced primary and secondary immune response against E.coli bacterin 
when compared to the pigs receiving the NRC recommended amount of 20 IU/Kg of 
feed and control pigs (Ellis and Vorhies, 197 6). This increase in hum oral response in 
vitamin E supplemented pigs was two to threefold greater than control pigs. Horses 
supplemented with vitamin E alone or a combination of vitamin E and selenium 
produced higher antibodies against tetanus toxoid and equine influenza virus 
(Baalsrud and Ovemes, 1986). The findings of these studies are similar to a more 
recent study on geriatric horses supplemented with vitamin E, which showed increased 
antibody production against tetanus toxoid vaccination (Petersson, Unpublished data). 
Serum antibodies in chickens vaccinated against Newcastle Disease virus were 
associated with higher hemagglutination inhibition titer and total immunoglobulins in 
vitamin E and selenium supplemented chickens compared to an unsupplemented 
group (Singh, et al., 2006). Dogs supplemented with parenteral vitamin E and 
selenium showed increased antibody titer against Taenia hydatigena and IgG 
concentration compared to controls (Kandil and Abou-Zeina, 2005) 
Research in Cattle 
Calves supplemented with 4180 IU/animal of oral vitamin E at weekly 
intervals showed increased IgM levels (Reddy, et al., 1986) but no change in total IgG 
concentrations (Reddy, et al., 1986). Further work by the same group reported higher 
antibody titers to Bovine herpes virus- I vaccine in the calves supplemented with 
vitamin Eat 125 IU/day/calf compared to the calves receiving 250 IU, 500 IU and the 
15 
control calves (Reddy, et al., 1987). Parenteral supplemenfation of vitamin E and 
selenium to the steers enhanced their humoral immune response against Pasteurella 
hemolytica vaccination (Droke and Loerch, 1989). A combination of selenium (0.1 
mg Se/kg bodyweight) and vitamin E (a-tocopherol acetate, 8 U/kg BW), to the cows 
during late pregnancy improved the production of specific antibodies against E.coli 
bacterin (Panousis, et al., 2001). A mixture of vitamin E and Freunds adjuvant 
resulted in higher antibody response in serum and milk against E.coli bacterin 
compared to Freund's alone as the adjuvant and control cows (Hogan, et al., 1993b). 
Research in Sheep 
Many of the studies evaluating the effect of vitamin E on immune response 
have investigated the influence on antibody production. Tengerdy et al. reported 
increased antibody response against Clostridium perfringens in sheep supplemented 
with 300 mg/Kg feed of dl a-tocopherol acetate (Tengerdy, et al., 1983). In the same 
study, they reported that adjuvant vaccine containing a fraction of vitamin E was more 
effective in producing antibody response than the oral supplementation. (Tengerdy, et 
al., 1983). In agreement with this study, vitamin E when used as an adjuvant with 
Brucella ovis vaccine provided greater protection to rams against epididymitis in 
comparision with Freunds incomplete adjuvant or commercial bacterin vaccinated 
rams (Afzal, et al., 1984, Tengerdy, et al., 1991). Vitamin E supplementation to sheep 
at 1000 ID/animal orally in the form of capsules did not prevent infection with 
Chlamydia or development of typical lung lesions, but it appeared to speed the 
recovery from infection (Stephens, et al., 1979). 
16 
Increased antibody response against parainfluenza-3 virus was seen in sheep 
supplemented with a combination of selenium (0.2mg/Kg feed) and vitamin E (30 
IV/Kg feed) (Reffett, et al., 1988). In contrast to this study, sheep supplemented with 
selenium (0.1 mg/kg BW) had a significant increase in Chlamydia antibody response 
but no effect was seen when selenium was given in combination with vitamin E 
(Giadinis, et al., 2000). Also, supplemental vitamin E (d-a-tocopherol acetate, 400 
IV/ewe/day) to the ewe during gestation period had no effect on the response to 
vaccination against parainfluenza-3 virus (Daniels, et al., 2000). 
Vitamin E and cell mediated immunity 
Supplementation of vitamin E (800 mg dl-alpha-tocopheryl acetate for 30 d) to 
healthy elderly subjects produced an increase in interleukin-2 production and 
mitogenic response to concanavalin A (Meydani, et al., 1990). Another study in 
elderly patients supplemented with vitamin E, significantly improved age-related early 
T cell signaling events in naive CD4(+) T cells (Marko, et al., 2007). Increased T 
helper cell activity was found in mice supplemented with vitamin E (Tanaka, et al., 
1979). Vitamin E has been shown to inhibit prostaglandin E2 production from 
macrophages enhancing cellular immunity (Moriguchi, et al., 1990, Romach, et al., 
1993). Calves supplemented with vitamin E showed increased lymphocyte 
proliferation when stimulated with mitogens (Reddy, et al., 1987). In agreement with 
this study, vitamin E and selenium supplementation to pigs (Larsen and Tollersrud, 
1981) and sheep (Larsen, et al., 1988b) also enhanced lymphocyte proliferation upon 
mitogenic stimulation. However, Politis et al. did not find any effect of vitamin E on 
lymphocyte proliferation in cows (Politis, et al., 1995). 
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CONCLUSION 
Results of studies exarmmng the effects of vitamin E supplementation in 
ruminants are variable and limited, but have shown enough benefits for additional 
investigation. Research undertaken in this dissertation is intended to enhance the 
evolving database of knowledge on vitamin E supplementation in late gestation sheep 
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Fig. 1.1. Development of the immune response in the calf. (Data from Morein B, 
Abusugra I, Blomqvist G. Immunity in neonates. Vet Immunol Immunopath 
2002;87:207-13; and Butler JE, Sink.ora M, Wertz N, et al. Development of the 
neonatal B and T cell repertoire in swine: implications for comparative and veterinary 
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Fig. 1.2. Structure of Tocopherols, Tocotrienols, relative antioxidant activity of their 
isoforms. Taken from Schneider, 2005. 
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Fig. 1.3. Antioxidant action of vitamin E. Adapted from Packer et al, 1997. 
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Table 1.1. Summary of literature on vitamin E in cattle 
Studr subjects VE dose Route Duration Effect Authors 
Calves 2000IU/day/weekly Parenteral At birth, 7 and 14 d IgM at day 22 of age: Pekmezci et al 
of life i (2009) 
JgG: i 
Calves VE-900, 1800, 2700 Parenteral At birth upto 12 wks JgG - Hidiriglou et al 
JU of age (3 wk Titer to KLH - (1992) 
interval) At 2700 IU JgM: i 
Pregnant cows Se(0.05 mg/kgBW) Parenteral 3 & 1.5 wks before GSH-Px of dam & Lacetera et al 
and VE calving calves: i (1996) 
(0.25JU/kgBW) JgG of dam & calves 
-
Pregnant Cows 3000 JUVE Parenteral at 10 d and 5 d prior N eutrophils killing Hogan et al, 
to claving ability: i (1992) 
Calves 125 JU/day/calf oral Birth to 24 wks of JgG against BHV 1: j Reddy et al (1987) 
age 
Table 1.2. Summary of literature on vitamin E in sheep 
Study subjects VE dosage Route Duration Effect Authors 
Pregnant sheep 400 oral 32 d before Ewe, lamb, colostral IgG - Daniels et al 
IU/ewe/day, lambing Anti PB titers - (2000) 
daily 
Pregnant sheep 1500 IU/ewe Parenteral 21 d before Lamb Serum IgG: j Gentry et al 
lambing Colostral IgG: - (1991) 
Lambs 30 IU/Kg feed oral 70 d period from SerumlgG - Reffet et al 
v 
(ace NRC the age of 2 mts Anti PB titers:jsec (1988) 
,) 1985) During vaccn immune response 
period GSH-Px activity: j 
Pregnant sheep 75 oral 4.5 mts prior to Serum & colostral IgG - Larsen et al 
IV/day/sheep parturition Anti tetanus toxoid: j (1988) 
Sheep 1500 IU/ewe oral 6 weeks Chlamydia psitaci titres - Giadnis et al 
· Weekly interval (2000) 
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CHAPTER2: 
Influence of Vitamin E on Innate and Hum oral components of the Immune 
system of Pregnant Ewes and their Lambs 
ABSTRACT 
The effect of parenteral administration of vitamin E during the pregnancy and 
lactation period of ewes and their lambs on innate and humoral components of the 
immune system was investigated in a 3 part study. 1.) Pregnant/Lactating ewes: 
Fifteen pregnant Dorset sheep were supplemented with vitamin E (30 IU d-a-
tocopherol /Kg body weight (BW), E, n=lO) or placebo (emulsified base, P, n=5) from 
the last trimester of gestation through weaning. Blood and colostrum were analyzed 
every 2 wk for a-tocopherol, selenium, glutathione peroxidase activity, lysozyme 
activity, total IgG and IgG antibodies against tetanus toxoid. 2.) Lambs (0-8wks): 
Lambs born to E and P supplemented ewes received either vitamin E (30 IU d-a-
tocopherol /Kg BW) or placebo (emulsified base) every 2 weeks from birth through 8 
wk of age. This resulted in four treatment groups: E/E (n=lO), E/P (n=l l), PIE (n=4), 
PIP (n=5). The lambs were sampled every other week and their blood was analyzed as 
for the ewes. 3.) Lambs (Vaccination period): When the youngest lamb reached 8 
wks of age all lambs were vaccinated as a group against Clostridium perfringens and 
Clostridium tetani. Booster vaccinations were given 4 wk later. Blood was sampled 
prior to primary vaccination, 1 wk post vaccination and then every 2 wk until 7 wk 
post vaccination. Results: Pregnant/Lactating ewes: Serum vitamin E concentrations 
mcreased over time in supplemented ewes as compared to placebo ewes. Colostrum 
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vitamin E levels were also increased in supplemented versus placebo ewes. Vitamin E 
supplementation did not influence plasma selenium, glutathione peroxidase activity 
and serum lysozyrne, IgG and IgG against tetanus toxoid in the serum or colostrum of 
ewes. There were fluctuations within treatment in the production of IgG in response 
to parturition. Lambs (0-8wks): Lambs directly supplemented with vitamin E in 
addition to maternal supplementation (E/E) had higher levels of serum a-tocopherol 
than the placebo group (PIP). There were no differences in plasma selenium, 
glutathione peroxidase activity, serum lysozyme, IgG and IgG against tetanus toxoid 
concentrations between groups. There was a loss of maternal antibodies over time in 
all lambs. Serum lysozyrne activity was higher at birth, prior to ingestion of 
colostrum, in lambs that received maternal vitamin E supplementation compared to the 
lambs that received only direct vitamin E supplementation. Lambs (Vaccination 
period): Serum a-tocopherol levels increased in lambs that received direct vitamin E 
supplementation (E/E and PIE) irrespective of maternal supplementation (PIP and 
E/P). Plasma selenium, glutathione peroxidase activio/, serum lysozyme and IgG did 
not differ between treatment groups. There was an increase in the production of IgG 
against tetanus toxoid in response to booster vaccination in PE lambs. Conclusions: 
Supplemental vitamin E to the ewes and lambs, at 30 IU/Kg BW, had a modest effect 
on parameters used in this study to assess innate and hum oral immunity. 
(Key words: vitamin E, ewe, IgG, tetanus toxoid) 
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INTRODUCTION 
Vitamin E has been shown to modulate immune function in several species of 
animals (Meydani, et al., 1986, Reddy, et al., 1987, Tengerdy, et al., 1983). The 
maternal immune system during the transition period is under increased physiological 
stress. The stress during pregnancy and increased metabolic demands during 
parturition and lactation result in increased production of reactive oxygen species 
leading to oxidative stress and a subsequent reduction in neutrophil function, antibody 
responses and cytokine production by immune cells (Spears and Weiss, 2008). Efforts 
to enhance immune function of pregnant animals through vitamin E supplementation 
have been met with varied results (Daniels, et al., 2000, Gentry, 1991, Giadinis, et al., 
2000, Larsen, et al., 1988). 
Maternal immune function will impact their offspring through maternal 
transfer of immune cells in the colostrum. The immune response of lambs to maternal 
vitamin E supplementation has been varied (Daniels, et al., 2000, Gentry, 1992) with 
either no effect (Capper, et al., 2005, Daniels, et al., 2000) or an increased effect 
(Gentry, 1992) on serum immunoglobulin G (IgG) reported. 
It has been generally assumed that there is no significant transfer of vitamin E 
across the placenta in ruminants (Njeru, et al., 1994). Recently however, 
supplementation of dietary vitamin E to ewes from 6 wks prepartum to 6 wks 
postpartum enhanced serum a-tocopherol levels in muscle tissue of lambs at birth 
even though plasma tocopherol concentration did not differ between groups (Capper, 
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et al., 2005). The potential of vitamin E supplementation of the ewe and her offspring 
to enhance immune function is an area that warrants further study. 
Therefore, the present experiment was designed to determine the effect of: 1.) 
Vitamin E supplementation on immune function in pregnant and lactating ewes; 2.) 
Direct vitamin E supplementation to the lamb superimposed on maternal 
supplementation on innate and adaptive immune function in lambs from birth through 
7 months of age. 
MATERIALS AND METHODS 
Animals 
Pregnant/lactating Dorset ewes (n= 18) ranging from 1-9 yrs of age and their lambs 
(n=30) were included in this study. All the ewes and lambs were maintained, 
treatments were administered, and samples were collected in accordance with the 
Institutional Animal Care and Use Committee (IACUC) of the University of Rhode 
Island. Ewes were fed with hay and grain whereas lambs had a free choice of feed. 
Feed analysis for various minerals, vitamin E and selenium are shown in Table 2.1. 
Body condition and weight were monitored for the ewes and lambs throughout the 
study. 
Study Design 
Pregnant/Lactating Ewes. Pregnant Dorset sheep were randomly assigned to 
receive either vitamin E (30 IU d-a-tocopherol /kg body weight (BW), E, n=lO) or 
placebo (P, n=8). The mean age of the ewes was 3.9 (±0.75) and 5.5 (±0.89) for 
vitamin E and placebo groups respectively. Intramuscular injections of d-a.-
tocopherol (Neogen, Lexington, KY) or equivalent quantity of placebo (emulsified 
base) were given every two weeks from the last trimester of gestation until weaning of 
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lambs at 3-4 months of age. Ewes were administered a yearly booster vaccination for 
Clostridium tetanus and Clostridium perfringens (C+D) (Colorado Serum Company, 
Denver, CO) approximately 6 weeks prior to parturition. 
Lambs (0-8wks). At birth, lambs born to vitamin E or placebo supplemented 
ewes, were assigned to receive either vitamin E (30 IU d-a-tocopherol/kg BW) or 
placebo (emulsified base) intramuscular injections from birth through 8 wk of age. 
This resulted in four treatment groups: 1.) Maternal E, Lamb E (E/E, n=lO) 2.) 
Maternal E, Lamb P (E/P, n=l 1) 3.) Maternal P, Lamb E (PIE, n=4) 4.) Maternal P, 
Lamb P (PIP, n=5). Following standard management practices all lambs received a 
single sodium selenite injection (O.lmg/kg BW) at 1 day of age. Body weight was 
monitored every two weeks throughout the study. 
Lambs (Vaccination). When the youngest lamb reached 8 weeks of age, all 
lambs were vaccinated as a group against Clostridium tetanus and Clostridium 
perfringens C+D (Colorado Serum Company, Denver, CO). Secondary vaccinations 
were administered 4 weeks later. The lambs were transitioned to receive their 
biweekly injections of vitamin E.(30 IU/Kg BW) or placebo (equivalent mls/Kg BW) 
as a group until the end of the study. Blood from lambs after vaccination was 
collected on the day of initial vaccination, 1 week later and every two weeks until the 
end of study. Lambs ranged from 8-14 wks of age at this start of this study period. 
Sample collection 
Blood samples were collected via jugular puncture from ewes every two weeks 
throughout the study period and from lambs, at birth (prior to colostrum consumption), 
weekly until one month of age and then every two weeks until 8 weeks of age. All 
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blood samples were collected pnor to biweekly injections of d-a.-tocopherol or 
placebo. All samples were analyzed for a.-tocopherol, selenium and glutathione 
peroxidase (GSH-Px) as a measure of antioxidant status, lysozyme as a measure of 
innate immunity, and IgG, and anti-tetanus toxoid IgG (IgGt) as a measure of humoral 
immune status. Lamb weights were measured to monitor growth performance. 
Blood was collected into a serum separator and EDT A vacutainers (Becton 
Dickinson, Franklin Lakes, NJ) for serum and plasma respectively. Tubes were 
centrifuged (1750 x g) at 25° C for plasma and 4° C for serum. Colostrum from the 
ewes was collected immediately after parturition. All the samples were stored at -80° 
C prior to analysis colostrum was centrifuged at 24,400 g for 20 minutes at 4° C, the 
fat layer removed, and the whey fraction was analyzed for lysozyme, IgG and IgG 
against tetanus toxoid. 
Alpha Tocopherol in Serum and Colostrum 
Samples were analyzed for a.-tocopherol content using established procedures 
at the Diagnostic Center for Population and Animal_ Health (DCP AH, Lansing, MI). 
Briefly, reverse phase HPLC (Hitachi, Pleasanton, CA) with a 3.5 um C18 column 
(Waters Corp, Milford, MA) and acetonitrile: methylene chloride: methanol mobile 
phase (70:20: 10) was used. Alpha tocopherol was detected at a wavelength of 292 nm 
and results are expressed as µg/ml. 
Selenium and GSH-Px in Plasma and Colostrum 
Samples were analyzed at the USDA Grand Forks Human Nutrition Research 
Center (Grand Forks, North Dakota) for selenium content and GSH-Px activity. 
Selenium concentrations were determined with electrotherma atomic absorption 
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spectrophotometry using a reduced Pd matrix modifier according to published 
procedure (Clark, et al., 1996) and results are expressed as ng/ml. GSH-Px was 
assayed by the glutathione reductase-coupled assay (Paglia and Valentine, 1967) as 
modified by Lawrence and Burke (Lawrence and Burk, 1976) using 0.25 mM H20 2 as 
substrate. Results are expressed as nanomoles ofNADPH/min/mg of protein. 
Lysozyme Activity 
Lysozyme activity was determined by the radial diffusion of samples through a 
suspension of live culture of Micrococcus luteus (ATCC 27141, Manassas, VA) in 
M/15 phsophate buffered agarose, pH 6.3 following published procedure (Sotirov, 
2005). The diameters of the lytic zones were compared with the lytic zones of the 
standard, hen egg white lysozyme (Sigma Aldrich, St.Louis, MO). Results are 
expressed as µg of hen egg white lysozyme equivalent per ml. 
IgG 
A commercial ELISA kit (Bethyl Labs, Montgomerry, Texas) was used to 
detect and quantify sheep lgG antibodies in the serum and colostrum. Briefly, rabbit 
antisheep lgG antibody is coated onto plates and incubated followed by blocking with 
0.05M tris buffered saline (Sigma-aldrich, St.Louis, MO) and addition of standard or 
serum sample. Rabbit antisheep IgG labeled with horse radish peroxidase enzyme was 
used as the detection antibody. Reaction terminated using stop solution (2 M H2So4) 
and the absorbance is read at 450 nm. Results are expressed as mg/ml of serum. 
lgG against tetanus toxoid 
Antibodies to tetanus toxoid were determined according to (Rosskopf, et al., 
2005) with some modifications. Briefly, 0.2 lf/ml (limit of flocculation units) of 
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commercially available tetanus toxoid was coated onto 96 well plates and incubated 
overnight at 4°C. Wells were blocked with phosphate buffered saline (PBS), followed 
by addition of standards and samples diluted in PBS (0.01 M with 0.05 % tween 20). 
Rabbit anti-sheep IgG horse radish peroxidase conjugated antibody (Bethyl Labs, 
Montgomerry, Texas) was used as developing antibody, followed by the addition of 
tetramethylbenzidine (TMB) susbtrate to the plates and incubated in dark for 15 
minutes before the reaction was terminated by 1.25 M H2S04. The results are 
expressed as absorbance units at 450nm (OD450). 
Statistical analysis 
The mixed procedure in SAS (SAS Inst. Inc., Cary, NC) was used to analyze 
serum a-tocopherol, lysozyrne activity, antibody concentrations, selenium, and GSH-
Px. The random effect of ewe or lamb was accounted for with a repeated measures 
approach. All outcome variables were assessed for normality. A logarithmic 
transformation was applied to non-normally distributed data. The appropriate error 
structure was assessed and applied for each outcome variable. Independent variables 
offered into each model included age, sex, treatment, and time. The interaction of 
treatment and time was evaluated for each model. Variables were removed by 
bacJ:cwards elimination based on order of least significance. Tukey's adjusted P-values 
were calculated for each variable to adjust for multiple 2-way comparisons within 
each model. Once the final model was chosen, residuals were checked for 
homoscedasticity, outliers, leverage cases, and normal distribution. Student's t-test 
was used to statistically analyze colostral content of a-tocopherol, selenium, GSH-Px 
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activity, lysozyme activity, IgG and IgGt. Significance was defined for all tests as P :S 
0.05. 
RESULTS 
Three ewes from the placebo group, though testing positive on ultrasound, did 
not lamb and therefore were removed from the study. This resulted in 5 animals in the 
placebo group (5.8±1.11 yrs) and 10 animals in the vitamin E group (3.9±0.75 yrs). 
Feed analysis of the mixed grass hay and grain fed to sheep and lambs is shown in 
Table 2.1. 
Pregnant/Lactating Ewes. 
Serum a-tocopherol increased over time in vitamin E supplemented 
ewes (P :S 0.001, Fig. 2.1) as compared to placebo supplemented ewes. There was 
also a treatment * week interaction for serum IgG (P :S 0.05, Fig. 2.2). Placebo 
supplemented ewes had a greater concentration of plasma selenium than vitamin E 
supplemented ewes (P :S 0. 05, Table 2.2). There was no effect of treatment or 
treatment by week interactions for plasma GSH-Px activity, serum lysozyme activity 
and serum IgGT. The colostrum from vitamin E supplemented ewes contained greater 
(P :S 0.05, Table 2.2) amounts of a-tocopherol than placebo supplemented ewes. 
There was no effect of vitamin E supplementation on colostral selenium, GSH-Px 
activity, lysozyme activity and IgG against tetanus toxoid concentrations. Treatment 
means(+/- SE) for all variables is shown in Table 2.2. 
An increase in IgG concentrations were seen in vitamin E supplemented ewes 
after their yearly booster vaccination against Clostridium tetanus and Clostridium 
perfringens (P :S 0.05, Fig. 2.2). There was no vaccination response in the placebo 
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supplemented ewes. There was a decrease in serum IgG in both vitamin E and 
placebo supplemented ewes during the transition period that was more pronounced in 
the placebo supplemented ewes (P ::S 0.05, Fig. 2.2). 
Plasma selenium, plasma GSH-Px activity, serum lysozyme activity, and serum 
IgGT increased over the length of the study period (P ::S 0.001, Table 2.3). 
When the effect of ewe age on the statistical model was determined plasma 
selenium concentrations were higher (P ::S 0.05) in younger ewes (::S 5yrs) as compared 
to older ewes (~ 7 yrs) and serum IgGT concentrations was greater in older than 
younger ewes. There was no effect of age on serum a-tocopherol, lysozyme activity, 
IgG and plasma GSH-Px acitivity. The effect of age for all the variables is shown in 
Table 2.4. 
Lambs (0-8wks). 
Serum a-tocopherol was greater in EE lambs than PP lambs (P ::S 0.05, Fig. 2.3) 
Lambs receiving maternal vitamin E supplementation but no direct supplementation 
(E/P) had elevated serum a-tocopherol over that of PIP that did not reach the level of 
significance (P = 0.0685). At birth, before suckling serum lysozyme activity was 
higher (P ::S 0.001, Fig. 2.4) in lambs that received maternal vitamin E supplementation 
compared to the lambs whose dams received placebo. There was no effect of 
treatment or treatment by week interaction for the plasma selenium and GSH-Px 
activity, and serum IgG and IgGT. Mean (+/- SE) of all variables by treatment is 
shown in Table 2.5. 
There was an effect of week (P ::S 0.001, Table 2.6) for serum vitamin E, lgG, 
lgGT, plasma selenium and GSH-Px activity. Serum IgG and IgG against tetanus 
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toxoid decreased over time in all lambs regardless of supplementation. Glutathione 
peroxidase and plasma selenium concentration increased over the length of the study. 
Lambs (Vaccination Period). 
Serum a-tocopherol increased over time in lambs receiving direct vitamin E 
supplementation (EE and PE) as compared to lambs supplemented with placebo (EP 
and PP, P :'.S 0.001, Fig. 2.5). Secondary vaccination against Clostridia tetani elicited a 
strong response in lambs receiving direct vitamin E supplementation but no maternal 
supplementation (PE, P :'.S 0.001, Fig. 2.6). There was no significant increase in 
production of antibody production in response to the secondary vaccination against 
Clostridia tetani in all other treatment groups. There was no effect of treatment or 
treatment by week interaction for the variables, selenium, GSH-Px activity, lysozyme 
activity and IgG. Mean± SEM for all the variables by treatment is shown in Table 
2.7. 
There was an effect of week of study (P :'.S 0.001, Table 2.8) for plasma 
selenium, GSH-Px activity, serum IgG and IgGT. Glutathione peroxidase activity and 
plasma selenium decreased in all lambs during the vaccination period. There was an 
increase in total serum IgG levels following primary and secondary vaccination in all 
the lambs. 
When the effect of lamb age, at the start of the vaccination period, on the 
statistical model was determined plasma selenium concentration were greater (P :'.S 
0.05) in older lambs(~ 12 wks) compared to younger (:'.S 12 wks) lambs. We did not 
observe an effect of age on serum a-tocopherol, lysozyme activity, IgG, IgGT and 
plasma GSH-Px acitivity. Mean± SEM by age oflamb at the start of the vaccination 
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period is shown in Table 2.9. When the effect oflamb sex on the statistical model was 
determined ewe lambs had a higher concentration of serum a-tocopherol (1.29 ± 0.06 
µg/ml, p:::; 0.001) than ram lambs (0.98 ± 0.05 µg/ml).There was no effect of sex for 
any other study variables. 
DISCUSSION 
Pregnant/Lactating Ewes 
As expected, there was an increase m serum a-tocopherol levels in 
supplemented versus placebo ewes. Serum or plasma a-tocopherol levels are 
routinely used as indicators of vitamin E status. Serum a-tocopherol concentrations > 
4 µg/ml are considered adequate, 2-4 µg/ml is marginal and animals with < 2 µg/ml 
are considered deficient according to cattle studies (Bass, et al., 2001). In our study, 
we observed marginally deficient tocopherol levels at baseline in all ewes and in 
placebo ewes throughout the study. Vitamin E supplemented ewes reached the 4 
ug/ml threshold by the end of the study. 
Placebo ewes had higher plasma selenium. levels compared to vitamin E 
supplemented ewes. The ewes in both the treatment groups were having adequate 
levels of selenium in their plasma (> 1 OOng/ml). Vitamin E did not influence plasma 
GSH-Px activity but the activity reached peak around parturition. This increase may 
be due to the increased oxidative stress around parturition. The plasma GSH-Px 
activity levels are in agreement with those of Reffet et al. (1988) in lambs who 
received selenium supplementation. Ewes supplemented with parenteral vitamin E 
(7.5 ID/Kg BW/2 wks) and selenium (0.lmg/Kg BW/2 wks) one month before 
lambing reported an increase in blood GSH-Px activity (Morgante, et al., 1999). The 
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vitamin E supplemented in this study was less than the dose of supplemental vitamin E 
administered in our study. The differences in the GSH-Px activity can be attributed to 
the selenium injections given before lambing. As selenium is an integral part of the 
enzyme GSH-Px, supplemental selenium might have a direct influence on the GSH-Px 
activity in the morgante et al. study. In the present study, selenium and GSH-Px 
activity were measured to assess antioxidant status of the animal as the soil in 
northeast regions are considered as deficient in selenium levels. However, the ewes in 
this study were not deficient in selenium levels. 
To date, there has been very little research on the effects of vitamin E on innate 
immunity in ruminants. In the present study, vitamin E had no influence on serum 
lysozyme activity. A similar trend was observed in ewes supplemented with vitamin 
E (7.5 IU/Kg BW/2 wks) and selenium (O.lmg/Kg BW/ 2wks) one month before 
lambing (Morgante, et al., 1999) and supplementation with vitamin E (15 IU/kg BW) 
to horses (K.H. Petersson, Unpublished data). The above reported studies 
administered lower dose of supplemental vitamin E compared to our study. Lack of 
significant effect on serum lysozyme concentrations in the present study suggests that 
oxygen independent killing mechanisms are insensitive to vitamin E status (Turner 
and Finch, 1990). 
Although there was no effect of vitamin E supplementation on serum IgG 
levels, the ewes in both the treatment groups behaved differently over time. Placebo 
ewes did not show an increase in IgG levels against Clostridium tetanus and 
Clostridium perfringens vaccination, whereas vitamin E supplemented ewes showed 
vaccination response. There was decrease in IgG levels around parturition for both the 
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groups, but the immunosuppression occurring during this period appeared to be 
diminished in the vitamin E supplemented ewes compared to placebo ewes. Lack of 
treatment effect can possibly be due to the small sample size of the placebo ewes 
which might have masked the effect of vitamin E during parturition. In agreement 
with our findings, Daniels et al. (2000) reported that oral vitamin E ( 400 IU/ewe/day) 
supplementation to the ewes during last trimester of gestation had no effect on serum 
IgG levels. This is in agreement with most of the studies conducted in cattle 
(Lacetera, et al., 1996) sheep (Larsen, et al., 1988, Reffett, et al., 1988) with varying 
doses of supplemental vitamin E. 
As expected, ewes vaccinated against tetanus toxoid produced greater amounts 
of tetanus specific antibodies in their serum. However, supplemental vitamin E did 
not influence the production of lgGT antibodies. These results were not in agreement 
with Larsen et al. (1988), who reported an increase in antibody titer to tetanus toxoid 
in ewes with dietary vitamin E supplementation (75 IU of a-tocopherol acetate/day). 
Although, the dose of supplemental vitamin E used in our study was higher than that 
of Larsen et al. we did not see any enhancement in the antibody titer. Plausible 
explanation for this difference could be the ewes in Larsen et al. study started with 
much lower levels of serum tocopherol and were less than 2 µg/ml throughout the 
study. And the supplemental vitamin E given at this period might have increased the 
production of antibodies. Also, the ewes were younger in Larsen et al. study 
compared to our study where we had a range of ewes from 1-9 yrs of age. 
The primary source of the nutrients for the ruminant newborns at birth is through 
colostrum. Several studies (Bass, et al., 2001, Pinelli-Saavedra, et al., 2008, Weiss, et 
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al., 1990) have shown that vitamin E supplementation to the dam during gestation 
enhances a-tocopherol concentration in their colostrum. These results were in 
agreement with the present study. As placental transfer of immunity is limited in 
ruminants, ruminant newborns are entirely dependent on their dam's colostrum for the 
immunoglobulins. Transfer of adequate amounts of IgG from dams to newborns 
minimizes the risk of infectious diseases until their own immune system comes into 
play. However, in the present study, supplementing vitamin E to the ewes during last 
trimester did not influence their colostral IgG and IgG against tetanus toxoid levels. 
No effect of supplemental vitamin E on colostral IgG in the present study agrees with 
the results reported in ewes supplemented with vitamin E (Daniels, et al., 2000) and 
cattle (Lacetera, et al., 1996) during late gestation. Also, supplemental vitamin E to 
ewes during the last trimester did not influence colostral lysozyme activity, selenium 
and GSH-Px activity. 
Lambs (0-8wks) 
Serum a-tocopherol levels were higher in lambs that were directly 
supplemented with vitamin E in addition to maternal supplementation (E/E) compared 
to placebo (PIP). The lambs receiving only maternal supplementation (E/P) tended to 
have higher means but did not reach significance level due to the small sample size of 
the placebo lambs. This increase at week 1 can be due to the ingestion of colostrum 
rich in vitamin E from supplemented animals. Interestingly, Capper et al. (2005) 
reported increased tissue vitamin E levels in lambs at birth born to supplemented 
ewes, even though their serum vitamin E levels were in low range. As we did not 
sacrifice any lambs at birth we do not know whether the tissue content of vitamin E 
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was greater in the maternally supplemented lambs. The serum a-tocopherol 
concentrations in this study were in the deficient range; however, it is feasible that the 
supplemental vitamin E was being stored in the tissues but not reflected in the serum 
values. Further research is warranted in this area. 
The selenium concentrations were low at birth but gradually increased over 
time as the lambs were feeding on grain which has selenium. There was a treatment 
by week interaction for the serum lysozyme activity in lambs. The lambs that were 
born to supplemented ewes had higher serum lysozyme activity at birth compared to 
the lambs that received only direct vitamin E supplementation. And the lambs were 
having higher means for serum lysozyme activity at birth compared to the rest of the 
life. This suggests that there might be increased lysozyme production in the fetal stage 
which might be reflected in the serum levels at birth before taking colostrum. And the 
vitamin E supplementation to the ewe might have influenced the production of 
lysozyme within the fetus. 
IgG and IgGT antibodies were not detectable at birth due to limited placental 
transfer, but reached peak concentrations after the ingestion of colostrum at week 1 of 
age. Thereafter, the maternal antibodies decreased overtime in spite of vitamin E 
supplementation. During neonatal life, greater amounts of serum IgG has been 
positively correlated with higher survival rates. Supplementing vitamin E to the 
newborns may help in reducing morbidity due to pathogens during the critical period 
from the loss of maternal antibodies to the production of antibodies by the newborns 
themselves. There is controversy in the literature on the effects of supplemental 
Vitamin Eon humoral immune response. Study by Gentry et al. (1992) reported that 
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lambs from ewes injected with vitamin E, 21 d before parturition contained greater 
concentrations of serum IgG than lambs born to control ewes. Gentry et al. explained 
that though vitamin E did not influence colostral IgG levels, it might have influenced 
the lambs ability to absorb immunoglobulins in the gut. However, we did not see such 
an effect and our results were in agreement with the studies supplementing vitamin E 
to ewes (Daniels, et al., 2000, Reffett, et al., 1988), cows (Lacetera, et al. , 1996) and 
pigs (Nemec, et al., 1994) during gestation which did not influence their newborns 
serum IgG levels. All of these studies vary in dose of supplemental vitamin E, interval 
at which they are administered, breed and species of animal. 
Lambs (Vaccination Period) 
Serum a-tocopherol levels were higher in lambs that were directly 
supplemented with vitamin E. The a-tocopherol concentrations in the E/E group 
differed from E/P group on the initial day of vaccination but the rest of the groups did 
not differ from each other on the initial day. The lambs that were supplemented 
directly with vitamin E had significantly higher levels of tocopherol compared to the 
lambs that received only maternal supplementation and the placebo lambs. This 
suggests that, the supplementation to the ewes during last trimester did not have a long 
term influence on their lamb's serum a-tocopherol levels. Also, the lambs that did not 
receive any supplementation (PP, EP) were having < 1 µg/ml of serum tocopherol, 
which is considered deficient. The lambs that received direct vitamin E 
supplementation had serum tocopherol levels ranging between 1-2.5 µg/ml which is 
considered as marginal to adequate. Hence, vitamin E supplementation helped the 
lambs to maintain adequate vitamin E status. 
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Vitamin E did not influence plasma selenium and GSH-Px activity. Although, 
there were no significant interactions for serum lysozyme activity the means of the 
lambs that received only direct vitamin E supplementation tended to be higher than the 
other groups. The lambs showed enhanced total IgG levels against both the primary 
and secondary vaccination against C/ostridium tetanus and C/ostridium perfringens 
but were not influenced by treatment. Reffet et al., (Reffett, et al., 1988) reported that 
dietary supplementation of vitamin E to the lambs that were challenged with 
I 
Parainfluenza-3 virus did not show any significant effect on total serum IgG levels. 
To date, there are very limited studies in supplementing vitamin E to the small 
ruminants and its influence on antibody production to tetanus toxoid vaccination. 
There was no treatment effect but the lambs that were directly supplemented with 
vitamin E showed greater secondary immune response. Lack of significance might be 
due to insufficient power from small sample size in PIE lambs. 
In summary, supplementing vitamin E parenterally during late gestation, direct 
supplementation to lambs did not appear to enhance the immune functions of sheep or 
the lambs in this study. Based upon these findings, parenteral vitamin E 
supplementation at the rate of 30 IU/kg BW/2 wks which is equal to 2 IU/kg BW/day 
to the ewes and lambs does not appear to be justified in improving their disease 
resistance. Since the study has started, the recommendations by NRC for vitamin E 
have been revised in 2007 (NRC, 2007) and the supplemental dosage is increased to 
10 IU/K.g BW/day to protect the small ruminants from infectious diseases and to 
extend the storage life of meat. Hence, it can also be possible that the vitamin E 
supplementation used in this study might not be sufficient to elicit a significant 
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immune response. Role of supplemental vitamin E in influencing immunocompetence 
might be more pronounced when the animals are undergoing environmental and 
pathogenic stress. Therefore, future studies taking small ruminants with sufficient 
sample size and challenged with parasitic or bacterial pathogens might give a better 
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Fig. 2.1. Mean (± SEM) serum a-
tocopherol concentrations of pregnant/ 
lactating ewes supplemented with d-a-
tocopherol (•, 30 IU d-a-tocopherol /kg 
BW/2wks, n=lO) or placebo (o, emulsified 
base, n=5). ! represents vaccination against 
C/ostridium tetanus and Clostridium 
perfringens. ~represents lambing. * 
represents P<0.001 vs placebo within 
week. + represents P<0.001 vs baseline 
within treatment. 
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Week of supplementation 
Fig. 2.2. Mean (± SEM) serum IgG 
concentrations of pregnant/ lactating ewes 
supplemented with d-a-tocopherol (•, 30 IU 
d-a-tocopherol /kg BW/2wks, n=lO) or 
placebo (o, emulsified base, n=5). l 
represents vaccination against Clostridium 
tetanus and Clostridium perfringens. 1----t 
represents lambing. *represents P<0.05 vs 
wk 4 within treatment. +represents P<0.05 
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Weekoflife 
Fig. 2.3. Mean (± SEM) serum tocopherol 
concentrations in lambs from 0-8 wks of life averaged 
over time. Vitamin E supplementation was given at 
30 JU/kg BW/2 wks or Placebo, emulsified base. 
Maternal vitamin E (E) Lamb E (E/E, n=IO), Maternal 
E, Lamb placebo (P) (E/P, n=l l) Maternal P, Lamb E 
(PIE, n=4), Maternal P, Lamb P (PIP, n= 5). * 
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Fig. 2.4. Mean (± SEM) serum lysozyme 
concentrations in lambs from 0-8 wks of life. Vitamin 
E supplementation was given at 30 IU/kg BW/2 wks 
or Placebo, emulsified base. Maternal vitamin E (E) 
Lamb E (EIE, •, n=lO), Maternal E, Lamb placebo 
(P) (EIP, o, n=l 1) Maternal P, Lamb E (PIE, •, n=4), 
Maternal P, Lamb P (PIP, o, n=5). * represents 
P<0.001 EIE 0 vs EIE all weeks, EIP 0 vs EIP all 
weeks. +represents PIE 0 vs EIE 0 and EIP 0. • 
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Weeks from primary vaccination 
Fig. 2!s. Mean (± SEM) a-tocopherol concentrations 
in serum of lambs during vaccination period; 
Vitamin E supplementation was given at 30 IU/kg 
BW/2 wks or Placebo, emulsified base. Maternal 
vitamin E (E) Lamb E (E/E, •, n=lO), Maternal E, 
Lamb placebo (P) (E/P, o, n=I I) Maternal P, Lamb E 
(PIE, •, n=4), Maternal P, Lamb P (PIP, o, n=5). i 
indicates initial and booster vaccination against 
C/ostridium tetanus and c/ostridium perfringens. * 
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Weeks from primary vaccination 
Fig. 2.6. Mean (± SEM) IgG concentrations against 
tetanus toxoid in serum of lambs during vaccination 
period; Vitamin E supplementation was given at 30 
IU/kg BW/2 wks or Placebo, emulsified base. 
Maternal vitamin E (E) Lamb E (E/E, •, n=IO), 
Maternal E, Lamb placebo (P) (E/P, o, n=l l) 
Maternal P, Lamb E (PIE,•, n=4), Maternal P, Lamb 
P (PIP, o, n=5). ! indicates initial and booster 
vaccination against Clostridium tetanus and 
c/ostridium perfringens. * represents P s; 0.001 vs wk 
0 & 3 within treatment. 
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Table 2.1. Results from proximate analysis and vitamin E analysis from composite 
feed samples collected over the study period 1. 
Components Grain Mix Hay 






Magnesium, % of DM 
Potassium, % of DM 
NEm, Meal/Kg of DM 
NEg, Meal/Kg ofDM 
Vitamin E, IU/Kg ofDM2 
a-Tocopherol, µgig of 
DM2 


























1Proximate analysis conducted by Dairy One Cooperative, Inc. (Ithica, New York). 
2 Analyzed at the Diagnostic Center for Population and Animal Health (Michigan State 
University, Lansing, MI). 
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2.2. Mean (±SEM) of study variables in pregnant/lactating ewes supplemented with d-a-tocopherol (30 IU d-a.-tocopherol /kg 
BW/2wks, n=lO) or placebo (emulsified base, n=5)1. 
Variables 
Serum/Plasma 




GSH-Px5•6 (run NADPH/min/mg protein) 
Se (ng/ml)6 
Colostrum7 




GSH-Px (run NADPH/min/mg protein) 
Se (ng/ml) 
Placebo 
2.14 ± 0.14 
16.65 ± 1.34 
0.97 ± 0.13 
0.28 ± 0.01 
0.97 ± 0.17 
215 ± 9.3a 
2.63 ± 0.53 
57.27 ± 7.3 
0.61±0.12 
0.40 ± 0.14 
0.24 ± 0.15 
238 ± 19.7 
Within a row, means with a superscript small letter differ (P < 0.05). 
Vitamin E 
3.4 ± 0.2 
19.03 ± 1.25 
0.91±0.12 
0.22 ± 0 
0.88 ± 0.09 
197 ± 7.4 
13.36 ± 2.51 a 
57.28 ± 4.51 
0.56 ± 0.12 
1.18 ± 0.38 
0.22 ± 0.06 
184 ± 22.07 
1Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
2Treatment*week interaction is present (P ~ 0.05). 
3Measured in serum. 
4IgG against tetanus toxoid measured in absorbance at 450nm. 
5Glutathione peroxidase. 
6Measured in plasma. 
7Variables were analyzed using Student's t test 
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Table 2.3. Effect of week (Mean± SEM) on study variables in pregnant/lactating ewes1• 2 
Week of Supplementation 3 
Variables 0 2 4 6 8 10 12 14 16 18 20 24 
IgGT(OD4so)5,o 0.59± 0.45± l.l l ± 1.17± 1.42 ± l.IO ± 0.92 ± 0.83 ± 0.99 ± 1.04 ± 0.84 ± 0.71 ± 
o.09•b 0.06bc O. l 5dc 0.11 dfg 0.11 flI 0.12dcgi o.10•ij o.o<)ik 0.11 degijk 0.11 dcgij 0.11 bjk 0.09bk 
Lysozyme6 
(µg/ml) 
0.19± 0.21 ± 0.2 ± 0.22 ± 0.22 ± 0.22 ± 0.25 ± 0.26 ± 0.22 ± 0.23 ± 






GSH-Px4•7 0.42± 0.66 ± 0.8± 0.7 1.04 ± 1.34 ± 1.03 ± 1.03 ± 1.02 ± 0.95 ± 1.02 ± 1.14 ± 
(run of 0.06 0.01•b o.o8•bcd ± o•ce 0.05cderg 0.2r 0.07df8 0.06cderg O. l cderg o.05•hcdeg 0.2abcdcg 0.25bdf 
NADPH/min/mg 
of protein) 
a-k Within a row, means without a common superscript small letter differ (P < 0.001). 
1Supplemented with d-a-tocopherol (30 IU d-a-tocopherol /kg BW/2wks, n=IO) or placebo (emulsified base, n=5). 
2Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Vaccination against C/ostridium tetanus and C/ostridium perfringens at week 2 of supplementation. 
4Glutathione peroxidase. 
5IgG against tetanus toxoid measured in absorbance at 450nm. 
6Measured in serum. 
7Measured in plasma. 
Table 2.4. Effect of age (Mean± SEM) on study variables in pregnant/lactating ewes. 
J, 2 





GSH-Px5'6 (nm NADPH/min/mg protein) 
Selenium (ng/m1)6 
> 7yrs 
2.82 ± 0.17 
18.68 ± 0.64 
1.2 ± o.osa 
0.25 ± 0.01 
0.97 ± 0.22 
188 ± 3.93 
Age 
:S 5 yrs 
3.06 ± 0.12 
17.94 ± 0.38 
0.81±0.04 
0.22 ± 0.01 
0.88 ± 0.09 
208 ± 2.3a 
Within a row, means with a superscript small letter differ (P :S 0.05). 
1Supplemented with d-a-tocopherol (30 IU d-a-tocopherol /kg BW/2wks, n=IO) or 
f lacebo (emulsified base, n=5). 
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Measured in serum. 
4IgG against tetanus toxoid measured in absorbance at 450nm. 
5Glutathione peroxidase. 
6Measured in plasma. 
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Table 2.5. Effect of treatment on Mean (±SEM) of study variables averaged over time 
in lambs from 0-8 wks of age supplemented with maternal and direct vitamin E (EIE, 
n=lO), only maternal (E/P, n=l 1), only direct (PIE, n=4), neither maternal nor direct 
(PIP, n=5) 1'2 
Variables 





























Within a row, means with a superscript small letter differ (P :S 0.05). 
1Supplemented with d-a-tocopherol (E, 30 IU d-a.-tocopherol /kg BW/2wks) or 
~lacebo (P, emulsified base). 
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Treatment*Time interaction is present. 
4Glutathione peroxidase. 
5IgG against tetanus toxoid measured in absorbance at 450nm. 
6Measured in serum. 
7Measured in plasma. 
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Table 2.6. Effect of week on Mean ( ± SEM) of study variables measured over the length of the study in 0-8 wk old lambs 1• 2 
Variables 
(Mean± SEM) 











1.14 ± 0.05b 
71.1±2.23 
1 
3.34 ± 0.39 
18.38 ± 1.23 
0.54 ± 0.06 
0.81 ± 0.08" 
91.3± 2.78 
Week oflife 
2 3 4 
1.92 ± 0.23 
13.9 ± 0.93 10.9 ± 0.58" 9.05±0.41" 
0.45 ± 0.05" 0.37 ± 0.05• 0.23 ± 0.03b 
0.7± 0.04" 0.74 ± 0.03" 0.79 ± 0.04"0 
87 ± 2.048 90.8 ± 2.37"b 97.7 ± 2.63b 
a-cwithin a row, means without a common superscript small letter differ (P ~ 0.001). 
6 8 
1.17 ± 0.12 
9.65± 0.66" 7.33 ± 0.43 
0.22 ± 0.03bc 0.14 ± 0.02° 
0.98 ± 0.07° 0.97 ± 0.06bc 
122 ± 2.99 139 ± 3.57 
1Lambs were divided in to four groups based on maternal and direct vitamin E (E/E, n=lO), only maternal (E/P, n=l 1), only direct 
(PIE, n=4), neither maternal nor direct (PIP, n=5). Supplementation was in the form of d-a-tocopherol (E, 30 IU d-a-tocopherol /kg 
BW/2wks) or placebo (P, emulsified base). 
2Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Glutathione peroxidase. 
4IgG against tetanus toxoid measured in absorbance at 450nm. 
5Measured in serum. 
6Measured in plasma. 
Table 2.7. Effect of treatment on Mean (±SEM) of study variables averaged over time 
in lambs during vaccination period supplemented with maternal and direct vitamin E 
(E/E, n=lO), only maternal (EIP, n=l l), only direct (PIE, n=4), neither maternal nor 
direct (PIP, n=5) 1'2 
Variables PIP PIE EIE EIP 
Vitamin E3•6 (µg/ml) 0.39±0.11 1.57±0.14 1.83±0.13 0.66±0.11 
IgG6 (mg/ml) 12.53±0.99 13.01±1 15.51±1.5 15.4±1.41 
Lysozyme6 (µg/ml) 0.34±0.10 0.41±0.10 0.35±0.05 0.24±0.03 
GSH-Px4'7 (nm of 0.92±0.1 0.69±0.08 0.96±0.1 0.98±0.11 
NADPH!minlmg of 
protein) 
Selenium7 (ng/ml) 150±8 160±15.3 165±6.5 154±7.2 
1Supplemented with d-a-tocopherol (E, 30 IU d-a-tocopherol /kg BW/2wks) or 
r,lacebo (P, emulsified base). 
Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Treatment*time interaction is present (P '.S 0.001). 
4Glutathione peroxidase. 
5IgG against tetanus toxoid measured in absorbance at 450nm. 
6Measured in serum. 
7Measured in plasma. 
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Table 2.8. Effect of week on Mean(± SEM) of study variables measured over the 
length of the study in lambs during vaccination period I, 2,3 
Variables Weeks from primary vaccination 
(Mean± SEM) 0 1 3 5 7 
IgG5 (mg/ml) 12.19 ±0.81"6 11.69 ± 0. 78° 16.05 ± 0.926 13.7 ± 0.7 19.6 ± 0.64 
GSH-Px4'6 (nm of 1.18 ± 0.07° 1.12± 0.06" 1.01±0.05" 0.74± 0.06 0.55 ± 0.05 
NADPH/min/mg of 
protein) 
Selenium6 (ng/ml) 164±4.11° 156 ± 455•b 161 ± 5.19" 152 ± 3.66b 155 ± 3.95b 
a-6within a row, means without a common superscript small letter differ (P < 0.001). 
1Lambs were divided in to four groups based on maternal and direct vitamin E (E/E, 
n=IO), only maternal (E/P, n=l 1), only direct (PIE, n=4), neither maternal nor direct 
(PIP, n=5). Supplementation was in the form of d-a.-tocopherol (E, 30 IU d-a-
tocopherol /kg BW/2wks) or placebo (P, emulsified base). 
2Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Initial vaccination against Clostridium tetanus and Clostridium perfringens was at wk 
0 and booster vaccination at wk 4 of the study. 
4Glutathione peroxidase. 
5Measured in serum. 
6Measured in plasma. 
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Table 2.9. Effect of age on Mean(± SEM) of study variables averaged over time in 
lambs during vaccination period1'2'3 
Variables Age 









1.23 ± 0.09 
14.58 ± 0.65 
0.36 ±0.02 
0.53 ± 0.03 
0.87 ± 0.32 
168 ± 2.4 
< 12 wks 
1.05 ± 0.07 
14.68 ± 0.54 
0.29 ± 0.01 
0.5 ± 0.03 
0.92 ± 0.37 
151±2.48a 
Within a row, means with a superscript small letter differ (PS 0.05). 
1Lambs were divided in to four groups based on maternal and direct vitamin E (E/E, 
n=lO), only maternal (E/P, n=l 1), only direct (PIE, n=4), neither maternal nor direct 
(PIP, n=5). Supplementation was in the form of d-a-tocopherol (E, 30 IU d-a-
tocopherol /kg BW/2wks) or placebo (P, emulsified base). 
2Variables were analyzed using PROC MIXED in SAS (SAS Inst. Inc, Cary, NC). 
3Initial vaccination against Clostridium tetanus and Clostridium perfringens was at wk 
0 and booster vaccination at wk 4 of the study. 
4Glutathione peroxidase. 
5IgG against tetanus toxoid measured in absorbance at 450nm. 
6Measured in serum. 
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Standard Operating Procedure for the High Performance Liquid 
Chromatography (HPLC) 
Standard Operating Procedure from Journal of Chromatography by Arnaud et al., 
572: 1-2, pg.103-16. 
The vitamins are sensitive to white light, oxidation, and to drying. Work under the 
gold light, keep the extract under nitrogen, and resuspend the extract as soon as 
possible. The following parameters describe a HPLC system used to separate and 
quantitate 0-tocopherol in samples extracted from serum and feed samples. 
1) Place 1 ml of serum in a 16 x 125 labeled test tube. Samples other than 1 ml (0.5, 
etc.) can be run in the above manner, remember to take into account the 
appropriate sample weight. Add a volume of 0.9% NaCl to equal 1 ml to all 
samples that are less than 1 ml. 
2) Add 1 ml of ethanol containing 0.01 % BHT and 0.1 % Ascorbic Acid. 
3) Add 20uL of apocaroteneal internal standard. 
4) Vortex for 5 minutes. 
5) Add 1 ml HPLC grade hexane. 
6) Vortex for 5 minutes. 
7) Centrifuge at 3000rpm for 10 minutes. 
8) Remove 0.5 ml of the top layer (hexane), dry using appropriate method. 
9) Resuspend in 0.5 mL of mobile phase (70:20: 10: Acetonitrile, Methylene 
Chloride, Methanol). 
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1 O) Transfer to HPLC vials and run on appropriate HPLC system. 
-Mobile phase is 70:20:10 (v/v/v) acetonitrile: methylene chloride: methanol. 
-Columns -guard column from Water's corp. Sentry guard column, Cl8, 3.5 
µm 
-analytical column: Water's corp. Symmetry C18, 3.5 µm, 4.6X75 mm 
column. 
-Flow rate: use a isocratic at a flow rate of 1.2 ml/min. 
I 
I I 
I -Detector: Photo diode array or variable wavelength UV detector is used. The 
wavelengths of interest are 292nm for alpha tocopherol, 265nm for 
cholecalciferol, 325nm for retinol and 450nm for beta carotene. 
-Injection volume: 50 µl 
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APPENDIX II 
Standard Operating Procedure for Lysoplate Assay 
Lysozyme activity is measured by Lysoplate assay described according to Sotirov et 
al., (2005) with some modifications. Analyze the samples in duplicates. 
~ Preparation of culture media for Micrococcus luteus 
Peptone ............................ 10 g 
Yeast extract .................... 5 g 
Sodium chloride .. . ........... 5 g 
Glucose ......................... . .. 1 g 
Tryptone peptone ..... . .... 11 g 
Agar .................................. 12 g 
Distilled water .................. 1 L 
Autoclave at 121 C for 15 minutes and pour into petridishes. 
~ Preparation of standards: Prepare 1 mg/ml of the stock solution of Hen Egg 
White Lysozyme(HEWL) (Sigma) in distilled water and store at -20° C in 
aliquots. 
1. Streak M.luteus culture (ATCC 27141) on the prepared media and incubate 
for 24 hr at 37°C. 
2. Next, wash the bacterial culture with sodium phosphate buffer (Na2HPo4 & 
NaH2Po4, 0.7M pH-6.3) and mix it to form uniform suspension. 
3. Adjust the optical density of the bacterial suspension to 1.8 and keep it in 
water bath at 60° C 
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4. Prepare 2% agarose in sodium phosphate buffer and keep it in water bath to 
attain 60°C temperature 
5. Then, mix equal quantities of bacterial suspension and agarose in a container. 
6. Mix it gently and pour 50 ml of agar+ bacterial suspension in the grid 
petri dishes. 
7. Allow it to cool and keep it in refrigerator for 10 minutes. 
8. Remove the petridishes from refrigerator and cut wells using 5 mm well 
cutter. 
9. Prepare lysozyme standards running from 3.125 to 0.048 µg/ml in serial 
dilutions 
10. Add 40 µl of standards and serum samples (directly without any dilution) or 
colostrum samples ( 1: 10 dilut~on) into the wells in duplicates. 
11. Incubate the loaded plates at 37° C for 24 hr. 
12. After the incubation, the diameters of the clear, lytic zones formed around the 
samples are compared with the lytic zones of HEWL standards. 
13. Results are expressed as µg ofHEWL equivalent per ml. 
73 
APPENDIX III 
ST AND ARD OPERA TING PROCEDURE FOR IgG ENZYME LINKED 
IMMUNOSORBANT ASSAY (ELISA) 
Serum and Colostral IgG was measured using Sheep IgG kit (Bethyl labs, 
E130-101). The kit included Purified sheep IgG, Rabbit antisheep IgG coating 
antibody, Rabbit antisheep IgG HRP conjugated secondary antibody and TMB 
susbtrate. 
Preparation of reagents and solutions 
1. Prepare coating buffer by dissolving contents of one carbonate -
bicarbonate capsule (Sigma-Aldrich; C-3041) in 100 ml distilled water to 
give 0.05 M and 9.6 pH. 
2. To prepare washing/sample/conjugate diluents/blocking buffers, dissolve 1 
packet of Tris buffer (Sigma-Aldrich; T-9039) containing 50mM Tris, 
O. l 4M NaCl, 0.05% Tween 20, pH 8.0 in 1 L of distilled water. 
3. Mix equal components of the TMB (Trimethyl benzidine) substrate just 
prior to use. 
4. 2 M H2S04 is used to terminate the reaction. 
ELISA Procedure 
1. Coat the wells ofNunc C bottom immunoplate 96 well plate (Fisher 
Scientific, 12-565-267) with a dilution of 1 µl of capture antibody to 100µ1 
of coating buffer. 
2. Incubate the plate for 60 minutes. 
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10. Dilute HRP conjugated rabbit antisheep IgG in conjugate diluent to 
1: 100,000 dilutions and add 1 OOul/well. 
11. Incubate for 60 minutes at room temperature and wash each well 5 times. 
12. Mix equal volumes of TMB substrate just before adding to the wells and 
transfer 1 OOul/well. 
13. Incubate for 15 minutes and 2M H2S04 to terminate the reaction. 
14. Read the plate at 450nm wavelength using microplate reader. 
15. Subtract the blank reading from each value. 
16. Create a standard curve using Gen 5 software and calculate the 
concentrations of the samples from the standard curve and the results are 
reported in mg/ml. 
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APPENDIX IV 
STANDARD OPERATING PROCEDURE FOR IgG AGAINST TETANUS 
TOXOID ENZYME LINKED IMMUNOSORBANT ASSAY (ELISA) 
IgG against tetanus toxoid were measured according to the protocol described by 
Rosskopf et al. (2005) with modifications. 
Reagents needed: 
Tetanus toxoid (150 Lf/ml) (Colorado serum company, 61415) 
Rabbit antisheep IgG HRP conjugated antibody (Bethyl labs, A130-101P) 
Wash buffer, blocking buffer, sample diluents and conjugate diluents: Phosphate 
buffered saline+ 0.05% Tween 20 
Carbonate bicarbonate buffer (Sigma-Aldrich; C-3041) 
1.25 MH2S04 
TMB susbtrate (Bethyl labs, E102) 
ELISA procedure 
1. Coat the wells of 96 well plate (Costar, 3590, flat bottom, high binding, 
nonsterile) with 0.2 Lf/ml of Tetanus toxoid in 0.05M carbonate buffer, pH 
9.6, lOOul/well. 
2. Incubate overnight at 4° C and wash the plate with washing buffer 3 times 
using plate washer (Biotek, ELX 405). 
3. Add 250ul/well of blocking buffer and incubate for 60 minutes 
4. Cover the plate with plate sealer and shake at 150rpm, 37 ° C for lhr, followed 
by washing step 3 times. 
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5. Dilute the serum samples to 1 :2000 or 1: 1000 dilutions in sample diluent. 
6. For colostrum samples, centrifuge at 24,400g at 4° C for 20 minutes. Remove 
11 
the fat layer from top and collect the sample from bottom and dilute to 
1: 10,000 dilutions. 
7. Add the samples in duplicates. 
8. Cover the plate with plate sealer and shake at 150rpm, 37° C for lhr, followed 
by washing step 3 times. 
9. Dilute HRP conjugated rabbit antisheep IgG in conjugate diluent to 1 :20,000 
dilutions and add 1 OOul/well. 
10. Cover the plate with plate sealer and shake at 150rpm, 37° C for lhr, followed 
by washing step 3 times. 
11. Mix equal volumes of TMB substrate just before adding to the wells and 
transfer 1 OOul/well. 
12. Incubate for 10 minutes and 1.25 M H2S04 to terminate the reaction. 
13. Read the plate at 450nm wavelength using microplate reader. 
14. Subtract the blank reading from each value. 
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Weeks from primary vaccination 
Effect of week on Average Daily Gain (Mean ± SEM) of lambs vaccinated against 
Clostridium tetanus and Clostridium perfringens. *represents P::::; 0.001 vs wk 1 & 5. 
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